Order a strain

. Contacts
. Culture unit
. Cryoconservation unit
. Forms / Documents
. Publications

Laboratoire de Parasitologie – Mycologie
CHRU de Montpellier
39, av. Charles Flahault
34295 MONTPELLIER cedex 5
France
+33 (0)4 67 33 23 50 (Tel)
+33 (0)4 67 33 23 58 (Fax)
———————————————-
MiVEGEC unit research
UMR 5290 CNRS / 224 IRD / UM

The BRCLeishmaniacatalog is also available online at :https://www.fbrcmi.fr

It is not exhaustive. Please do not hesitate to contact a biologist in charge of the collection (see below).

Fee schedule of the services provided by the BRC-Leishmania

How to order one or more strains ?

The cession of one or more strains by the BRC-Leishmaniais possible after sending and acceptance of aResearch Collaboration Agreement RCA orMaterial Transfer Agreement MTA). For requesting strain(s), please follow the steps below:

1 –Contact a Biologist in charge of the collection

Pr L. Lachaud:Email

Dr C. Ravel:Email

2 –The Biologist contacted will be your correspondent; he/she will ask you some information about the research project involvingLeishmaniastrains:

• The nature and number of strains required,
• The data associated with the samples needed for research,
• A short description of the research project,
• The financial conditions, depending on the eligibility to an RCA or MTA.

3 –The signature of the RCA or MTA constitutes a contract stipulating the obligations of stakeholders identified.

4 –The BRC-Leishmaniarequests the authorization of the Depositor of the strain(s) and the Scientific Council of the BRC, except if the user is the same person as the Depositor. Taking into account any embargo period clearly mentioned in the strain deposit record of the BRC engaging stakeholders, the BRC-LeishmaniaOperational Manager is in charge for authorizing the release of the strains.

5 –The BRCLeishmaniathen sends the strains and associated data to the User.

NB: The transport of the strain(s) is under the responsibility of the BRC-Leishmania, and is performed by a specialized and certified company. However, the BRC does not pay for the transport, which must be paid by the User.

Terms of availability

Security

Appropriate safety precautions for this type of biological material should be used. Consult theWHO « Laboratory biosafety manual »or the CDC« Biosafety in microbial and biomedical laboratories »manual for more information.

BRC-Leishmaniaservices warranty

The viability of theLeishmaniastrain(s) provided is warranted for 7 days from the date of shipment, only if the strain(s) is/are stored and cultured according to the information included on the product information sheet enclosed in the package. BRC-Leishmanialists the media formulation that has been found to be effective for the strain(s) shipped (seeCulture Unitor specifications enclosed in the shipment). While other, unspecified media may also produce satisfactory results, a change in media may affect recovery, growth and/or function of the strain(s). If an alternative medium formulation is used, the BRC-Leishmaniawarranty for viability is no longer valid.

Disclaimers

The strain(s) is/are intended for laboratory research purposes only and not intended for use in humans.

While BRC-Leishmaniahas made and makes every effort to ensure the authenticity of the strains and to include accurate and up-to-date information on the product sheet, it cannot absolutely guarantee its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BRCLeishmaniacannot warrant that such information has been confirmed to be accurate.

The biological material is sent with the condition that the User is responsible for its safe storage, handling, and use. BRCLeishmaniais not liable for any damages or injuries arising from receipt and/or use of the strains.

Please see the Material Transfer Agreement (MTA) or the Research Collaboration Agreement for further details regarding the use of the biological material.